Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × mirdametinib × CNS × Clear all

Phase

Status

Recruiting 3 Not yet recruiting 1 Completed 1 Available 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Glioma 1 Glioblastoma 1

Interventions

Temozolomide 20 Magnetic Resonance Spectroscopy 9 Radiotherapy 8 Blood Specimen Collection 8 Cyclophosphamide 6 AZD 6244 6 pembrolizumab 5 Bevacizumab 5 Specimen Handling 4 Radiation 4 Nivolumab 4 fludarabine 3 dinutuximab 3 aflutinib 3 Surgical Procedures, Operative 3 Saline Solution 3 Pemetrexed 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Biopsy 3 vorasidenib 2 tovorafenib 2 tislelizumab 2 osimertinib 2 naxitamab 2 gallium maltolate 2 fludarabine phosphate 2 Topotecan 2 Surveys and Questionnaires 2 Spinal Puncture 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡